New Jersey · 2026-2027 Regular Session · Bill

A 4852: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Enacted Last action July 8, 2026: Approved P.L.2026, c.40.

Plain-language summary

A 4852 is a bill introduced in the New Jersey House on May 4, 2026. According to its official title, it concerns: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*. Primary sponsor: Andrea Katz (Democratic), Sweeney, Marisa, Kearney, Vincent M., Chris Tully (Democratic), Joe Vitale (Democratic), Vin Gopal (Democratic), Raj Mukherji (Democratic). It lists 2 additional sponsors. Most recent recorded action (July 8, 2026): Approved P.L.2026, c.40.

Sponsors

Primary sponsors: Andrea Katz (Democratic); Sweeney, Marisa; Kearney, Vincent M.; Chris Tully (Democratic); and 3 more. 2 co-sponsors.